Biophage to conduct study for Alberta Agriculture
2007-04-03 06:13 MT - News Release
Dr. Rosemonde Mandeville reports
BIOPHAGE SIGNS MILESTONE CONTRACT WITH ALBERTA AGRICULTURE AND FOOD
Biophage Pharma Inc. has signed a groundbreaking contract with Alberta Agriculture and Food to conduct a pilot study for the large-scale production and purification of bacteriophage preparations in a biofermentor. Securing this contract marks the beginning of a new business opportunity for Biophage in large-scale production of phage preparations. This is highly opportune as phages have been ruled to be safe for use as food additives.
Biophage has seen a renewed interest in phage therapy since the first groundbreaking announcement by the U.S. FDA (Aug. 18, 2006) regarding the safety use of a bacteriophage preparation made of six phages against Listeria monocytogenes on ready-to-eat meat and poultry products.
Dr. Rosemonde Mandeville, president and chief executive officer, said: "We are very pleased to announce Biophage's first contract for the large-scale production of phages in a biofermentor. This new business opportunity is expected to generate a continuous stream of revenues in the coming years. Since the FDA's approval of applying bacteriophages as food additives, we received numerous inquiries from producers who understand the commercial potential of this innovative, safe and environment-friendly solution for the control of bacterial contaminations." Dr. Mandeville added "Biophage is continuously seeking strategic partnerships for the co-development, outlicensing and commercialization of its phage-based proprietary approach for the detection, prevention and control of deadly micro-organisms."
News 
Market Data 
Discover 
